Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes

Stock Information for Senseonics Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Senseonics Holdings Inc.

SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Blue Horizon Announces Breakthrough Success by 14125339 Canada Inc. in 4D Chip Testing & Unveils Revolutionary Telecommunication Network Prototype
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
Blue Horizon Announces Strategic Acquisition of Miss Globe Group Inc.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.